Overview

A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants

Status:
Not yet recruiting
Trial end date:
2027-10-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the time to all-cause death and time to death due to pulmonary arterial hypertension (PAH) or first hospitalization due to PAH in the overall study population and within each cohort.
Phase:
Phase 4
Details
Lead Sponsor:
Actelion